Application of microRNA in diagnosis and treatment of ovarian cancer

K Banno, M Yanokura, M Iida, M Adachi… - BioMed research …, 2014 - Wiley Online Library
Ovarian cancer has a poor prognosis because early detection is difficult and recurrent
ovarian cancer is usually drug‐resistant. The morbidity and mortality of ovarian cancer are …

[HTML][HTML] MicroRNA in ovarian cancer: biology, pathogenesis, and therapeutic opportunities

SN Chen, R Chang, LT Lin, CU Chern, HW Tsai… - International journal of …, 2019 - mdpi.com
Ovarian cancer comprises one of the three major malignant tumor types in the female
reproductive system. The mortality rate of this cancer is the highest among all gynecological …

MicroRNAs as biomarkers for early diagnosis, prognosis, and therapeutic targeting of ovarian cancer

Y Mirahmadi, R Nabavi, F Taheri… - Journal of …, 2021 - Wiley Online Library
Ovarian cancer is the major cause of gynecologic cancer‐related mortality. Regardless of
outstanding advances, which have been made for improving the prognosis, diagnosis, and …

[HTML][HTML] Current status and implications of microRNAs in ovarian cancer diagnosis and therapy

MS Zaman, DM Maher, S Khan, M Jaggi… - Journal of ovarian …, 2012 - Springer
Ovarian cancer is the fifth most common cancer among women and causes more deaths
than any other type of female reproductive cancer. Currently, treatment of ovarian cancer is …

[HTML][HTML] MicroRNA: a new and promising potential biomarker for diagnosis and prognosis of ovarian cancer

MK Pal, SP Jaiswar, VN Dwivedi… - Cancer biology & …, 2015 - ncbi.nlm.nih.gov
Epithelial ovarian cancer (EOC) is the leading cause of death among all gynecological
malignancies. Despite the technological and medical advances over the past four decades …

Updates and current challenges in microRNA research for personalized medicine in ovarian cancer

V Mandilaras, M Vernon… - Expert Opinion on …, 2017 - Taylor & Francis
Introduction: Ovarian cancer (OC) is the second most common and the most lethal of the
gynecological malignancies. Currently, there exists no effective screening tool for OC …

MicroRNA as biomarker in ovarian cancer management: Advantages and challenges

V Kumar, S Gupta, K Varma, M Sachan - DNA and Cell Biology, 2020 - liebertpub.com
Ovarian cancer is the most prevalent gynecological malignancy affecting women throughout
the globe. Ovarian cancer has several subtypes, including epithelial ovarian cancer (EOC) …

Differential role of microRNAs in prognosis, diagnosis, and therapy of ovarian cancer

A Mahdian-Shakib, R Dorostkar, M Tat… - Biomedicine & …, 2016 - Elsevier
Ovarian cancer (OC) is the most lethal of malignant gynecological cancers, and has a very
poor prognosis, frequently, attributable to late diagnosis and responsiveness to …

The role of microRNAs in ovarian cancer

Y Kinose, K Sawada, K Nakamura… - BioMed research …, 2014 - Wiley Online Library
Ovarian cancer is the most lethal of malignant gynecological tumors. Its lethality may be due
to difficulties in detecting it at an early stage and lack of effective treatments for patients with …

miRNAs and ovarian cancer: An overview

B Deb, A Uddin, S Chakraborty - Journal of cellular physiology, 2018 - Wiley Online Library
Ovarian cancer (OC) is the sixth most common cancer in women globally. However, even
with the advances in detection and therapeutics it still represents the most dangerous …